# Italy Continuous Glucose Monitoring System Market

> Italy Continuous Glucose Monitoring System Market Research Report: Size, Share, Trend Analysis By Applications (Diabetes Management, Critical Care, Sports Nutrition), By Product Type (Sensor, Transmitter, Receiver, Integrated Device), By End-user (Hospitals, Homecare, Diabetes Clinics), and By Technology (Microdialysis, Spectroscopy, Electrochemical) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 12.33%
- **2024:** $ 300 Million
- **2025:** $ 336.99 Million
- **2035:** $ 1,078 Million
- **Key Players:** Dexcom (US), Abbott (US), Medtronic (US), Roche (CH), Senseonics (US), GlucoMe (IL), Insulet (US), B. Braun (DE)

**Report ID:** MRFR/MED/48293-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/italy-continuous-glucose-monitoring-system-market-50050

---

## Market Summary

## **Italy Continuous Glucose Monitoring System Market Overview**

As per MRFR analysis, the Italy Continuous Glucose Monitoring System Market Size was estimated at 127.2 (USD Million) in 2023.The Italy Continuous Glucose Monitoring System Market is expected to grow from 138.9(USD Million) in 2024 to 414.7 (USD Million) by 2035. The Italy Continuous Glucose Monitoring System Market CAGR (growth rate) is expected to be around 10.455% during the forecast period (2025 - 2035).

**Key Italy Continuous Glucose Monitoring System Market Trends Highlighted**

The market for continuous glucose monitoring systems in Italy is changing significantly in favor of patient-centered technologies and individualized medical care. Due to an aging population and lifestyle factors, diabetes is becoming more common in Italy, which is driving up demand for sophisticated monitoring systems that offer real-time data.

As part of a larger movement to incorporate technology into healthcare, the Italian healthcare system is aggressively encouraging the usage of digital health solutions. This has given producers the chance to improve their product lines by emphasising the continuous glucose monitoring devices' accuracy, use, and accessibility.

Continuous glucose monitoring system adoption is further encouraged by a discernible increase in patient and healthcare professional education and understanding of diabetes management. In keeping with current trends toward proactive health management, the government's efforts to promote better diabetes control highlight the value of preventative treatment.

Additionally, telemedicine and remote patient monitoring are growing in popularity, which enables Italian patients to get data analysis and support without having to visit the clinic frequently. In addition to supporting the expanding trend of healthcare digitization, this offers businesses the chance to create integrated systems that improve monitoring's usability.

Recent events show that technology companies and healthcare practitioners are working together to develop creative solutions that address the requirements of people with diabetes. The market is growing as more attention is being paid to systems that offer analytical capabilities to assist users in making well-informed health-related decisions.

In order to meet the growing need for improved diabetes management in Italy, these developments highlight the necessity for continuous monitoring systems that are not only efficient but also blend in smoothly with users' daily lives.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Italy Continuous Glucose Monitoring System Market Drivers**

**Rising Prevalence of Diabetes in Italy**

The Italy's Continuous Glucose Monitoring System Market is significantly driven by the rising prevalence of diabetes across the country. According to the Italian Ministry of Health, as of 2022, approximately 3.5 million Italians are diagnosed with diabetes, accounting for almost 5.7% of the population. This number is expected to increase, leading to a growing demand for effective glucose monitoring solutions.

Organizations such as the Italian Diabetes Society (SID) are actively promoting the importance of continuous glucose monitoring systems to manage diabetes more effectively, thus boosting market growth. The increasing awareness and need for better diabetes care solutions are essential drivers for the expansion of the continuous glucose monitoring segment within the healthcare industry in Italy.

**Technological Advancements in Glucose Monitoring Devices**

Continuous glucose monitoring technology is evolving rapidly, making devices more accurate, user-friendly, and accessible. With advancements in sensors and wireless communication, patients can now receive real-time data on glucose levels, which greatly enhances diabetes management.

Companies such as Dexcom and Abbott are leading innovations in this space, with new product releases and features that ensure higher precision and ease of use. The Italian Ministry of Health has recognized the importance of adopting such technologies to improve healthcare outcomes, further driving the proliferation of continuous glucose monitoring systems in Italy.

**Government Initiatives and Support for Diabetes Management**

The Italian government has increased investments and resources dedicated to diabetes prevention and management initiatives. Programs that aim to subsidize medical devices, including continuous glucose monitoring systems, are being introduced across various regions in Italy.

Research from the Italian National Health Institute indicates that adequate funding and health policies are crucial for promoting the adoption of effective diabetes management tools. As a result, the collaboration between governmental bodies and healthcare organizations fosters a conducive environment for the growth of the Italy Continuous Glucose Monitoring System Market.

**Growing Awareness and Patient Education**

There is a notable increase in awareness among patients regarding diabetes management and the importance of continuous glucose monitoring. Campaigns initiated by health organizations such as the Italian Diabetes Federation (FID) aim to educate patients about the benefits of using advanced monitoring systems.

According to a recent survey, approximately 70% of patients indicated that they would opt for continuous glucose monitoring if it were made available to them, reflecting a shift in patient attitudes towards innovative healthcare solutions.

This rising awareness is a significant driver for the Italy Continuous Glucose Monitoring System Market, as it promotes the adoption of these advanced systems for improved health outcomes.

**Italy Continuous Glucose Monitoring System Market Segment Insights**

**Continuous Glucose Monitoring System Market Application Insights**

The Italy Continuous Glucose Monitoring System Market is witnessing significant development, particularly in the Application segment, which encompasses various critical areas, including Diabetes Management, Critical Care, and Sports Nutrition.

Diabetes Management stands out as a vital aspect due to the high prevalence of diabetes in Italy, prompting the need for consistent and effective monitoring solutions. With an increasing number of diabetes cases fueled by lifestyle changes and an aging population, the demand for reliable continuous glucose monitoring tools is on the rise.

The Critical Care sector also plays an essential role as hospitals and healthcare facilities prioritize advanced technologies for real-time glucose monitoring in critically ill patients, ultimately ensuring better patient outcomes and enhanced safety.

Moreover, the Sports Nutrition application has emerged as a noteworthy area of growth as athletes increasingly recognize the importance of precise glucose monitoring to optimize performance, recovery, and overall health.

As the awareness about nutrition and fitness continues to grow among various demographics in Italy, the integration of continuous glucose monitoring in sports nutrition is likely to gain traction.

Overall, the Application segment reflects a dynamic landscape enriched with growth drivers and challenges, poised to meet the diverse needs of the Italian population while contributing to the overall enhancement of health management strategies.

The continuous investment in Research and Development activities further supports innovative advancements in this market, indicating substantial efforts to address both the challenges and opportunities that lie ahead.

The Italy Continuous Glucose Monitoring System Market is thus expected to significantly influence both healthcare and lifestyle sectors, highlighting its importance in contemporary societal health management.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Continuous Glucose Monitoring System Market Product Type Insights**

The Italy Continuous Glucose Monitoring System Market is categorized by Product Type into various components that play essential roles in diabetes management. Among these, sensors are crucial as they provide real-time glucose level data, allowing users to make informed decisions about their health.

Transmitters are equally important, facilitating the wireless transmission of glucose readings to compatible devices, thereby enhancing user convenience. The receiver segments the data for easy accessibility and understanding, while integrated devices streamline the monitoring process by combining multiple functions into a single unit.

This integration is gaining traction in Italy, driven by the increasing prevalence of diabetes and the demand for efficient health management solutions. The Italian government has been focusing on improving diabetes care through technology, further driving the adoption of these devices.

The continuous evolution in sensor accuracy, transmitter range, and receiver functionalities demonstrates the market's commitment to meeting the needs of patients effectively. Each product type contributes significantly to the overall usability and effectiveness of Continuous Glucose Monitoring Systems in Italy, showcasing the dynamics of this sector.

**Continuous Glucose Monitoring System Market****End-user****Insights**

The Italy Continuous Glucose Monitoring System Market within the End-user segment is primarily shaped by the demands of hospitals, home care, and diabetes clinics, which play pivotal roles in managing diabetes effectively.

Hospitals represent a significant portion of the market, providing comprehensive care and robust monitoring capabilities critical for acute patients. Homecare options are becoming increasingly vital as they empower patients to manage their glucose levels independently in a familiar environment, an important aspect considering the rising prevalence of diabetes in Italy.

Diabetes clinics focus specifically on providing tailored treatment plans and consistent monitoring, which is essential for effective diabetes management and preventing complications. The growing trend towards patient-centered care and advancements in technology encourage the use of continuous glucose monitoring systems across these settings, facilitating better treatment outcomes.

Overall, the shifting dynamics toward personalized healthcare solutions and the increased integration of technological innovations are driving broad acceptance of these systems across the various End-user settings in Italy, thus presenting substantial growth opportunities in the market.

**Continuous Glucose Monitoring System Market Technology Insights**

The Technology segment of the Italy Continuous Glucose Monitoring System Market is significant due to its focus on advanced methodologies for accurate glucose monitoring. Microdialysis technology plays a crucial role in monitoring glucose levels by analyzing interstitial fluid, thus providing real-time insights for better diabetes management.

Spectroscopy, on the other hand, utilizes light interaction with glucose molecules, offering a non-invasive approach that appeals to a wide range of patients seeking comfort and convenience. Electrochemical technology dominates the market through its reliability and precision, making it a preferred choice among healthcare professionals for continuous monitoring.

As the demand for diabetes management solutions grows in Italy, driven by factors such as an increasing prevalence of diabetes and an aging population, these technologies are pivotal in addressing the needs of patients.

The ongoing innovations in these areas are expected to enhance the effectiveness and user-friendliness of continuous glucose monitoring systems, ultimately contributing to the overall improvement of diabetes care in Italy.

**Italy Continuous Glucose Monitoring System Market Key Players and Competitive Insights**

The Italy Continuous Glucose Monitoring System Market is experiencing notable dynamics characterized by competitive insights that highlight the strategic positioning of leading players within this segment. With the increasing prevalence of diabetes and a growing awareness of the advantages offered by continuous glucose monitoring systems, the market is witnessing a surge in demand for innovative solutions.

Players in this market are focusing on technological advancements, strategic collaborations, and a robust distribution network to cement their presence. Furthermore, the regulatory landscape, evolving reimbursement policies, and heightened competition among existing firms are shaping market trends, influencing product development and delivery models.

These competitive insights underscore the continual drive for market expansion and the importance of addressing unique patient populations within the Italian healthcare system. B. Braun has established a significant footprint within the Italy Continuous Glucose Monitoring System Market, leveraging its strong reputation in the medical technology sector.

The company is well-regarded for its commitment to quality and innovation, utilizing advanced technologies to deliver efficient solutions. B. Braun emphasizes user-friendly interfaces and connectivity features in its products, enhancing patient adherence and management of diabetes.

The company's strong distribution channels and partnerships with healthcare providers allow it to effectively reach its target demographic, ensuring accessibility to its advanced monitoring systems.

Furthermore, B. Braun's research and development focus enables the company to continually refine its offerings and address emerging market needs, underscoring its strength in the competitive landscape of continuous glucose monitoring.

Terumo Corporation is another key player in the Italy Continuous Glucose Monitoring System Market, distinguishing itself through a comprehensive range of medical devices and services designed to improve patient care.

The company offers a suite of glucose monitoring products designed to provide accurate and real-time data, facilitating better diabetes management for users. Terumo's market presence in Italy is strengthened by its emphasis on research and development, which fuels innovation and ensures that its products remain competitive.

The company also actively engages in mergers and acquisitions to expand its product portfolio and enhance its operational capabilities within the region. Terumo's strengths lie in its strong customer relationships, effective marketing strategies, and continued investment in technology, positioning it as a formidable competitor in the ongoing evolution of continuous glucose monitoring systems in Italy.

**Key Companies in the Italy Continuous Glucose Monitoring System Market Include:**

- B. Braun
- Terumo Corporation
- A. Menarini Diagnostics
- Senseonics
- Dexcom
- Medtronic
- Ascensia Diabetes Care
- Novo Nordisk
- Ypsomed
- GlucoMe
- Roche
- Lifescan
- Insulet Corporation
- Abbott

**Italy Continuous Glucose Monitoring System****Market****Developments**

In recent months, the Italy Continuous Glucose Monitoring System Market has seen significant developments, with companies like Dexcom and Abbott launching new CGM sensors tailored to better meet the needs of Italian diabetic patients.

The introduction of these advanced sensors reflects the growing demand for innovative glucose monitoring solutions in Italy, where diabetes management is becoming a critical public health issue. In June 2023, Medtronic announced an expansion of its product line in Italy, enhancing its market presence.

Additionally, in July 2023, A. Menarini Diagnostics established a partnership with Roche to enhance data interoperability, which is crucial for healthcare providers in Italy to streamline patient management. Though no recent mergers and acquisitions have been reported among key players such as B. Braun, Terumo Corporation, or Insulet Corporation in Italy, the market continues to flourish.

Italy's healthcare system is increasingly adopting technology-driven solutions to boost diabetes care efficiency, supported by government initiatives aimed at improving chronic disease management. Over the last two to three years, the market has witnessed continuous growth, reflecting increasing awareness and the rising prevalence of diabetes in the region.

**Italy Continuous Glucose Monitoring System Market Segmentation Insights**

**Continuous Glucose Monitoring System Market Application Outlook**

- Diabetes Management
- Critical Care
- Sports Nutrition

**Continuous Glucose Monitoring System Market Product Type Outlook**

- Sensor
- Transmitter
- Receiver
- Integrated Device

**Continuous Glucose Monitoring System Market End-userOutlook**

- Hospitals
- Homecare
- Diabetes Clinics

**Continuous Glucose Monitoring System Market Technology Outlook**

- Microdialysis
- Spectroscopy
- Electrochemical

## Market Drivers

### Rising Diabetes Prevalence

The continuous glucose-monitoring-system market in Italy is experiencing growth due to the increasing prevalence of diabetes. According to recent data, approximately 5.5 million individuals in Italy are living with diabetes, which represents around 10% of the adult population. This rising number of diabetes cases necessitates effective management solutions, leading to a heightened demand for continuous glucose monitoring systems. As healthcare providers and patients seek to improve glycemic control, the adoption of these systems is likely to increase. Furthermore, the Italian healthcare system is focusing on preventive care, which aligns with the capabilities of continuous glucose monitoring technology. This trend suggests that the continuous glucose-monitoring-system market will continue to expand as more individuals require reliable and efficient methods to manage their blood glucose levels.

### Government Initiatives and Funding

Government initiatives aimed at improving diabetes care are playing a crucial role in the continuous glucose-monitoring-system market in Italy. The Italian government has been actively promoting diabetes management programs, which include funding for innovative medical technologies. Recent reports indicate that the government allocated approximately €50 million to support diabetes care initiatives, which includes the adoption of continuous glucose monitoring systems. This financial backing not only encourages healthcare providers to incorporate these technologies into their practices but also makes them more accessible to patients. Consequently, the continuous glucose-monitoring-system market is likely to experience growth as these initiatives foster a more supportive environment for diabetes management solutions.

### Technological Integration in Healthcare

The integration of advanced technologies into the healthcare sector is significantly influencing the continuous glucose-monitoring-system market in Italy. Innovations such as mobile health applications and telemedicine are enhancing the functionality of glucose monitoring systems. For instance, many continuous glucose monitors now offer connectivity features that allow users to track their glucose levels in real-time via smartphones. This technological synergy not only improves patient engagement but also facilitates better communication between patients and healthcare providers. As a result, the market is likely to see an increase in the adoption of these systems, as they provide a more comprehensive approach to diabetes management. The continuous glucose-monitoring-system market is thus positioned to benefit from ongoing technological advancements that enhance user experience and clinical outcomes.

### Growing Demand for Personalized Medicine

The shift towards personalized medicine is significantly impacting the continuous glucose-monitoring-system market in Italy. Patients are increasingly seeking tailored healthcare solutions that cater to their individual needs, particularly in managing chronic conditions like diabetes. Continuous glucose monitoring systems offer personalized data that can help patients and healthcare providers make informed decisions regarding treatment plans. This trend is further supported by the increasing availability of data analytics tools that enhance the interpretation of glucose monitoring results. As the demand for personalized healthcare solutions continues to rise, the continuous glucose-monitoring-system market is expected to expand, driven by the need for customized diabetes management strategies.

### Increased Focus on Preventive Healthcare

The continuous glucose-monitoring-system market in Italy is benefiting from a growing emphasis on preventive healthcare. As awareness of the importance of early intervention in diabetes management increases, more individuals are seeking proactive solutions to monitor their glucose levels. Continuous glucose monitoring systems provide real-time data that can help identify trends and prevent complications associated with diabetes. This proactive approach aligns with the Italian healthcare system's goals of reducing long-term healthcare costs and improving patient outcomes. Consequently, the continuous glucose-monitoring-system market is likely to see an uptick in demand as more patients and healthcare providers recognize the value of preventive measures in managing diabetes.

## Future Outlook

The [Continuous Glucose Monitoring System Market](https://www.marketresearchfuture.com/reports/continuous-glucose-monitoring-system-market-20310) is projected to grow at a 12.33% CAGR from 2025 to 2035, driven by technological advancements, increasing diabetes prevalence, and rising health awareness.

**New opportunities:**

- Development of integrated mobile health applications for real-time data analysis.
- Expansion of subscription-based models for continuous monitoring services.
- Partnerships with healthcare providers for bundled service offerings.

By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships.

## Segment Insights

### By Application: Diabetes Management (Largest) vs. Critical Care (Fastest-Growing)

In the Italy continuous glucose-monitoring-system market, Diabetes Management holds the largest market share, reflecting its significance in managing blood glucose levels for patients with diabetes. This segment dominates the overall market due to the increasing prevalence of diabetes and a growing awareness of the importance of continuous monitoring for effective diabetes management. Meanwhile, Critical Care is emerging as a vital segment, driven by advancements in technology and the rising demand for precise glucose monitoring in critical medical situations.

Growth trends in these segments are primarily influenced by innovations in sensor technology and an increasing shift towards personalized healthcare solutions. The rising elderly population in Italy and the associated health issues contribute to the demand for continuous glucose monitoring systems in both Diabetes Management and Critical Care. Additionally, sports nutrition is gaining traction, as athletes and fitness enthusiasts seek real-time data for better performance optimization, further diversifying the applications of these systems in the market.

Diabetes Management: Dominant vs. Critical Care: Emerging

Diabetes Management remains the dominant application segment within the Italy continuous glucose-monitoring-system market, characterized by its established usage and integration in diabetes treatment regimens. This segment benefits from a wide variety of devices designed to cater to the diverse needs of patients, including user-friendly interfaces and remote monitoring capabilities. On the other hand, the Critical Care segment is emerging as a vital area of growth, offering high-precision glucose monitoring essential in hospital settings and for patients with acute conditions. This segment is marked by rapid technological advancements and increased investments, reflecting a growing recognition of the necessity for accurate and timely glucose readings in critical environments.

### By Product Type: Sensor (Largest) vs. Integrated Device (Fastest-Growing)

In the Italy continuous glucose-monitoring-system market, the product type segment includes Sensors, Transmitters, Receivers, and Integrated Devices, with Sensors commanding the largest market share. This dominance is attributed to their widespread acceptance among users and healthcare providers due to their reliability and accuracy in monitoring glucose levels. Following Sensors, Integrated Devices are gaining traction as they combine multiple functionalities into one unit, appealing to consumers' desire for convenience and efficiency in diabetes management.

The growth trends indicate a strong inclination towards Integrated Devices, identified as the fastest-growing segment in the market. As technology advances, users are increasingly favoring devices that offer seamless integration with other health monitoring systems and mobile applications. This trend is driven by the need for real-time data sharing and improved user experience. The rise in diabetes cases and the push for innovative healthcare solutions are accelerating the demand for such advanced products.

Sensor (Dominant) vs. Integrated Device (Emerging)

Sensors in the Italy continuous glucose-monitoring-system market represent the dominant product type, well-established for their high accuracy and reliability. They are essential for continuous glucose monitoring, granting users the confidence needed to manage their diabetes effectively. With continuous advancements in sensor technology, these devices are becoming smaller, more comfortable, and more user-friendly. Conversely, Integrated Devices are emerging rapidly, merging the functions of sensors, transmitters, and receivers into singular devices that simplify the user experience. This innovation not only minimizes the need for multiple devices but also offers users advanced features such as data integration with smartphones and healthcare platforms. Both segments are vital as they cater to the diverse requirements of users, promoting better diabetes management.

### By End User: Hospitals (Largest) vs. Homecare (Fastest-Growing)

In the Italy continuous glucose-monitoring-system market, the distribution of market share among end users reveals that hospitals are the largest segment, reflecting their extensive utilization of glucose monitoring for diabetes management and critical care. Homecare, while smaller in share, is rapidly gaining traction due to a shift towards patient-centric care, enabling individuals to manage their conditions more comfortably at home. Meanwhile, diabetes clinics also contribute significantly, but they hold a steady position comparative to the other segments.

Growth trends in this segment are heavily influenced by increasing diabetes prevalence and an overarching shift toward personalized healthcare solutions. The rise in homecare can be attributed to technological advancements in monitoring devices and patients' growing preference for remote management of their health. Furthermore, hospitals continue to adopt continuous glucose monitoring technologies to enhance patient outcomes, demonstrating the critical role they play in diabetes care and management.

Hospitals (Dominant) vs. Homecare (Emerging)

Hospitals remain the dominant force in the continuous glucose-monitoring-system market due to their established infrastructure and patient base, providing comprehensive care for a wide range of diabetes cases. These settings are equipped with advanced technologies and skilled healthcare professionals, allowing for precise monitoring and immediate intervention when necessary. Meanwhile, homecare is emerging as a significant player as it aligns with modern healthcare's emphasis on decentralization and self-management. Technological innovations, such as mobile applications and remote monitoring systems, empower patients to take charge of their health, leading to improved adherence to treatment regimens. The growing acceptance of homecare solutions speaks to changing consumer preferences and the desire for more flexible healthcare options.

### By Technology: Electrochemical (Largest) vs. Microdialysis (Fastest-Growing)

In the Italy continuous glucose-monitoring-system market, Electrochemical technology holds the largest market share, dominating due to its proven effectiveness and reliability in blood glucose monitoring. Microdialysis, on the other hand, is the fastest-growing segment, gaining traction with its ability to continuously measure glucose levels in interstitial fluids, making it increasingly appealing for users seeking a holistic monitoring approach.

The growth trends in this market segment are influenced by the rising incidences of diabetes and the increasing demand for advanced healthcare solutions. Innovations in Electrochemical technology have solidified its lead, while the emerging Microdialysis segment showcases enhanced accuracy and patient comfort, driving interest and investment into these technologies. The focus on personalized medicine further accelerates these growth trajectories, positioning both technologies as pivotal in diabetes management.

Technology: Electrochemical (Dominant) vs. Microdialysis (Emerging)

Electrochemical technology is the dominant force in the Italy continuous glucose-monitoring-system market, characterized by its high accuracy, rapid readings, and affordability. This technology's reliability in monitoring blood glucose levels has made it a preferred choice among patients and healthcare providers alike. In contrast, Microdialysis is regarded as an emerging technology that offers unique benefits, such as minimal invasiveness and the ability to provide continuous glucose monitoring with real-time data. The increasing awareness among consumers about diabetes management and convenient monitoring devices creates demand for Microdialysis. Both technologies play essential roles in improving patient outcomes, but their distinct characteristics cater to different segments of the market.

## Competitive Benchmarking

The continuous glucose-monitoring-system market in Italy is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for diabetes management solutions. Key players such as Dexcom (US), Abbott (US), and Medtronic (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Dexcom (US) focuses on innovation, particularly with its latest CGM technology that integrates seamlessly with digital health platforms, while Abbott (US) emphasizes accessibility through cost-effective solutions. Medtronic (US) is leveraging its extensive experience in diabetes care to expand its product offerings and enhance patient engagement through digital tools. Collectively, these strategies contribute to a competitive environment that prioritizes innovation and patient-centric solutions.
In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several players vying for market share. However, the influence of major companies is substantial, as they set industry standards and drive technological advancements. This competitive structure fosters an environment where innovation is crucial for maintaining market relevance.
In October 2025, Abbott (US) announced the launch of its new CGM system, which features advanced algorithms for improved accuracy and user experience. This strategic move is significant as it not only enhances Abbott's product portfolio but also positions the company to better compete against emerging players in the market. The introduction of this technology is likely to attract a broader customer base, particularly among those seeking reliable and user-friendly diabetes management solutions.
In September 2025, Medtronic (US) unveiled a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its CGM systems. This collaboration is strategically important as it aligns with the growing trend of digital health solutions, enabling patients to receive real-time data and support from healthcare professionals. Such initiatives may enhance patient adherence to treatment plans and improve overall health outcomes, thereby solidifying Medtronic's position in the market.
In August 2025, Dexcom (US) expanded its distribution network in Italy by partnering with local pharmacies, aiming to increase accessibility to its CGM products. This strategic action is indicative of a broader trend towards localized distribution, which may enhance customer engagement and satisfaction. By making its products more readily available, Dexcom (US) is likely to capture a larger share of the market, particularly among patients who prefer purchasing through familiar retail channels.
As of November 2025, current trends in the continuous glucose-monitoring-system market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) into product offerings. Strategic alliances are increasingly shaping the competitive landscape, as companies collaborate to enhance technological capabilities and expand their market reach. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on innovation, technology, and supply chain reliability. This transition may redefine how companies position themselves in the market, ultimately benefiting patients through improved products and services.

## Recent News & Developments

In recent months, the Italy Continuous Glucose Monitoring System Market has seen significant developments, with companies like Dexcom and Abbott launching new CGM sensors tailored to better meet the needs of Italian diabetic patients.

The introduction of these advanced sensors reflects the growing demand for innovative glucose monitoring solutions in Italy, where diabetes management is becoming a critical public health issue. In June 2023, Medtronic announced an expansion of its product line in Italy, enhancing its market presence.

Additionally, in July 2023, A. Menarini Diagnostics established a partnership with Roche to enhance data interoperability, which is crucial for healthcare providers in Italy to streamline patient management. Though no recent mergers and acquisitions have been reported among key players such as B. Braun, Terumo Corporation, or Insulet Corporation in Italy, the market continues to flourish.

Italy's healthcare system is increasingly adopting technology-driven solutions to boost diabetes care efficiency, supported by government initiatives aimed at improving chronic disease management. Over the last two to three years, the market has witnessed continuous growth, reflecting increasing awareness and the rising prevalence of diabetes in the region.

## Report Scope

| MARKET SIZE 2024 | 300.0(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 336.99(USD Million) |
| MARKET SIZE 2035 | 1078.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 12.33% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Dexcom (US), Abbott (US), Medtronic (US), Roche (CH), Senseonics (US), GlucoMe (IL), Insulet (US), B. Braun (DE) |
| Segments Covered | Application, Product Type, End User, Technology |
| Key Market Opportunities | Integration of advanced data analytics in continuous glucose-monitoring-system market enhances personalized diabetes management solutions. |
| Key Market Dynamics | Rising demand for continuous glucose-monitoring systems driven by technological advancements and increasing diabetes prevalence in Italy. |
| Countries Covered | Italy |

## Frequently Asked Questions

**Q: What is the projected market valuation for the Italy continuous glucose-monitoring-system market by 2035?**
A: The projected market valuation for the Italy continuous glucose-monitoring-system market is $1078.0 Million by 2035.

**Q: What was the overall market valuation in 2024?**
A: The overall market valuation in 2024 was $300.0 Million.

**Q: What is the expected CAGR for the Italy continuous glucose-monitoring-system market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Italy continuous glucose-monitoring-system market during the forecast period 2025 - 2035 is 12.33%.

**Q: Which application segment had the highest valuation in 2024?**
A: In 2024, the Diabetes Management application segment had the highest valuation at $150.0 Million.

**Q: What are the key players in the Italy continuous glucose-monitoring-system market?**
A: Key players in the market include Dexcom, Abbott, Medtronic, Roche, Senseonics, GlucoMe, Insulet, and B. Braun.

**Q: Which product type segment is projected to grow the most by 2035?**
A: The Sensor product type segment is projected to grow significantly, with a valuation range of $90.0 Million to $320.0 Million.

**Q: What is the valuation range for the Homecare end user segment in 2024?**
A: The valuation range for the Homecare end user segment in 2024 was $150.0 Million to $550.0 Million.

**Q: Which technology segment had the highest valuation in 2024?**
A: The Electrochemical technology segment had the highest valuation in 2024, ranging from $120.0 Million to $438.0 Million.

**Q: What is the projected valuation for the Critical Care application segment by 2035?**
A: The projected valuation for the Critical Care application segment by 2035 is expected to reach $90.0 Million to $350.0 Million.

**Q: How does the market for Diabetes Clinics as an end user segment compare to others in 2024?**
A: In 2024, the Diabetes Clinics end user segment had a valuation of $60.0 Million to $208.0 Million, which is lower than both Homecare and Hospitals.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/italy-continuous-glucose-monitoring-system-market-50050*